Literature DB >> 18814143

Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells.

Tzu-Hsiu Lai1, Yi-Chin Fong, Wen-Mei Fu, Rong-Sen Yang, Chih-Hsin Tang.   

Abstract

Chondrosarcoma is a type of highly malignant tumor with a potent capacity to invade locally and cause distant metastasis. Chondrosarcoma shows a predilection for metastasis to the lungs. The stromal cell-derived factor 1 (SDF-1), constitutively secreted by human lung epithelium cells, has been shown to function in a key role for recruitment of neutrophils. Here, we found that human chondrosarcoma tissues and chondrosarcoma cell lines had significant expression of CXCR4 (SDF-1 receptor), which was higher than normal cartilage and human chondrocyte. SDF-1alpha and lung epithelium cells conditioned medium (LECM) induced the invasiveness of chondrosarcoma cells. SDF-1 siRNA inhibited LECM-induced invasion of chondrosarcoma cells and SDF-1alpha also directly induced the cell surface expression of alphavbeta3 but not alpha2beta1 and alpha5beta1 integrin. Activations of ERK and NF-kappaB pathways after SDF-1 treatment was demonstrated, and SDF-1alpha-induced expression of alphavbeta3 integrin and invasion activity was inhibited by the specific inhibitor and mutant of ERK and NF-kappaB cascades. Taken together, our results indicate that lung derived-SDF-1alpha enhances the invasiveness of chondrosarcoma cells by increasing alphavbeta3 integrin expression through the CXCR4/ERK/NF-kappaB signal transduction pathway. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18814143     DOI: 10.1002/jcp.21601

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents.

Authors:  K V Greco; A J Iqbal; L Rattazzi; G Nalesso; N Moradi-Bidhendi; A R Moore; M B Goldring; F Dell'Accio; M Perretti
Journal:  Biochem Pharmacol       Date:  2011-09-16       Impact factor: 5.858

Review 2.  Enhancing the efficacy of mesenchymal stem cell therapy.

Authors:  Michalis Mastri; Huey Lin; Techung Lee
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

3.  miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.

Authors:  Xiaojuan Sun; Cherie Charbonneau; Lei Wei; Qian Chen; Richard M Terek
Journal:  Mol Cancer Res       Date:  2015-05-26       Impact factor: 5.852

4.  Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells.

Authors:  Ju-Fang Liu; Yi-Chin Fong; Chih-Shiang Chang; Chun-Yin Huang; Hsien-Te Chen; Wei-Hung Yang; Chin-Jung Hsu; Long-Bin Jeng; Chih-Yi Chen; Chih-Hsin Tang
Journal:  Mol Cancer       Date:  2010-02-23       Impact factor: 27.401

5.  CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis.

Authors:  Xiaojuan Sun; Cherie Charbonneau; Lei Wei; Wentian Yang; Qian Chen; Richard M Terek
Journal:  Mol Cancer Ther       Date:  2013-05-17       Impact factor: 6.261

6.  Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells.

Authors:  Ming-Wei Chang; Jem-Mau Lo; Hsueh-Fen Juan; Hsin-Yi Chang; Chun-Yu Chuang
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

7.  The role of chemokine receptor CXCR4 in the biologic behavior of human soft tissue sarcoma.

Authors:  Roger H Kim; Benjamin D L Li; Quyen D Chu
Journal:  Sarcoma       Date:  2010-12-22

8.  The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets.

Authors:  E David; F Blanchard; M F Heymann; G De Pinieux; F Gouin; F Rédini; D Heymann
Journal:  Sarcoma       Date:  2011-05-22

9.  CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression.

Authors:  Xiaojuan Sun; Lei Wei; Qian Chen; Richard M Terek
Journal:  Mol Cancer       Date:  2010-01-26       Impact factor: 27.401

10.  MAPK/ERK Signaling in Osteosarcomas, Ewing Sarcomas and Chondrosarcomas: Therapeutic Implications and Future Directions.

Authors:  Chandhanarat Chandhanayingyong; Yuhree Kim; J Robert Staples; Cody Hahn; Francis Youngin Lee
Journal:  Sarcoma       Date:  2012-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.